Dolby Laboratories (DLB) EBITDA Margin Growth (3y) (2016 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (3y) (Qtr) |
| 1 |
Relx |
81.40 Bn |
81.16 Bn |
- |
- |
| 2 |
Rentokil Initial |
79.56 Bn |
78.10 Bn |
- |
-4,558.00 |
| 3 |
Cintas |
69.26 Bn |
69.08 Bn |
1.45 Bn |
282.00 |
| 4 |
Copart |
33.09 Bn |
28.01 Bn |
971.24 Mn |
-355.00 |
| 5 |
UL Solutions |
20.56 Bn |
20.32 Bn |
381.00 Mn |
628.00 |
| 6 |
Global Payments |
19.88 Bn |
14.69 Bn |
1.70 Bn |
-300.00 |
| 7 |
Rb Global |
19.08 Bn |
18.89 Bn |
869.50 Mn |
2,023.00 |
| 8 |
Aramark |
13.57 Bn |
13.16 Bn |
426.35 Mn |
128.00 |
| 9 |
Amentum Holdings |
5.65 Bn |
5.74 Bn |
345.00 Mn |
- |
| 10 |
Dolby Laboratories |
5.15 Bn |
4.56 Bn |
350.90 Mn |
-51.00 |
| Date | Value |
| Mar 27, 2026 |
-51.00 |
| Dec 26, 2025 |
-1,016.00 |
| Sep 26, 2025 |
-8.00 |
| Jun 27, 2025 |
-64.00 |
| Mar 28, 2025 |
1,620.00 |
| Dec 27, 2024 |
-338.00 |
| Sep 27, 2024 |
105.00 |
| Jun 28, 2024 |
-682.00 |
| Mar 29, 2024 |
386.00 |
| Dec 29, 2023 |
-2,127.00 |
| Sep 29, 2023 |
-1,229.00 |
| Jun 30, 2023 |
-849.00 |
| Mar 31, 2023 |
-106.00 |
| Dec 30, 2022 |
1,145.00 |
| Sep 30, 2022 |
-740.00 |
| Jul 1, 2022 |
440.00 |
| Apr 1, 2022 |
-1,746.00 |
| Dec 31, 2021 |
305.00 |
| Sep 24, 2021 |
894.00 |
| Jun 25, 2021 |
2,310.00 |
| Mar 26, 2021 |
-220.00 |
| Dec 25, 2020 |
1,089.00 |
| Sep 25, 2020 |
-8,074.00 |
| Jun 26, 2020 |
-1,756.00 |
| Mar 27, 2020 |
-120,012.00 |
| Dec 27, 2019 |
-21,754.00 |
| Sep 27, 2019 |
-64,044.00 |
| Jun 28, 2019 |
-38,209.00 |
| Mar 29, 2019 |
-163,577.00 |
| Dec 28, 2018 |
-78,098.00 |
| Sep 28, 2018 |
-1,031.00 |
| Jun 29, 2018 |
-20,245.00 |
| Mar 30, 2018 |
-68.00 |
| Dec 29, 2017 |
-37,230.00 |
| Sep 29, 2017 |
-122,318.00 |
| Jun 30, 2017 |
-103,248.00 |
| Mar 31, 2017 |
-70,803.00 |
| Dec 30, 2016 |
-56,350.00 |
| Sep 30, 2016 |
-36,006.00 |
| Jul 1, 2016 |
18,085.00 |